0
Skip to Content
BLOODPAC
BLOODPAC
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
BLOODPAC Portal
BLOODPAC Data Commons
Educational Seminars
Upcoming Events
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
BLOODPAC
BLOODPAC
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
BLOODPAC Portal
BLOODPAC Data Commons
Educational Seminars
Upcoming Events
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
Folder: About
Back
Our Story
Our Team
Our Community
Annual Reports & Financials
Contact Us
Folder: Approach
Back
How We Work
Reimbursement & Policy
Public Comments
Collaborative Studies
Folder: Data
Back
BLOODPAC Portal
BLOODPAC Data Commons
Folder: Events
Back
Educational Seminars
Upcoming Events
Folder: Impact
Back
BLOODPAC Publications
Data Elements
Frameworks & Standards
Member Publications
Folder: Resources
Back
BLOODPAC Dictionary
BLOODPAC Governance
Beyond ctDNA
Insights
Job Opportunities
Videos
MEMBER LOGIN
Initial Release of Open Data
News Laura Tramontozzi 2/12/18 News Laura Tramontozzi 2/12/18

Initial Release of Open Data

Read More
Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium
Cheyenne Jankiewicz 2/10/17 Cheyenne Jankiewicz 2/10/17

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Read More
Newer Posts

ABOUT

BLOODPAC is a consortium managed by the Center for Computational Science Research, Inc. (CCSR), which is an Illinois based 501 (c)(3) not-for-profit corporation. Our mission is to accelerate the development, validation, and accessibility of liquid biopsy assays to improve outcomes for patients with cancer. To do so, we lead a pre-competitive collaborative infrastructure that enables the sharing of information and building of consensus among stakeholders in industry, academia, regulatory bodies, payers, and government agencies.